Computational and Experimental Insights into Pharmacological Potential: Synthesis, In Vitro Evaluation, and Molecular Docking Analysis of Bioactive Urea and Thiourea Derivatives.

This study delves into the synthesis, in vitro assessment, and molecular docking analysis of bioactive urea and thiourea derivatives, which have gained attention in pharma chemistry due to their versatile chemical reactivity and potential therapeutic applications. One pot synthetic methodology was employed to create a diverse class of compounds. Subsequent in vitro assessments, including antimicrobial assays, unveiled the pharmacological potential of these derivatives, offering insights into their ability to inhibit pathogenic microorganisms.

Fabrication of 1 × integrated power splitters with arbitrary power ratio for single and multimode photonics.

Compact power splitters are essential components in integrated optics. While 1 × 2 power splitters with uniform splitting are widely used, a 1 × splitter with arbitrary number of ports and arbitrary splitting ratio is yet to be demonstrated. In this work we address this problem.

In silico inspired design of urea noscapine congeners as anticancer agents: Chemical synthesis and experimental evaluation using breast cancer cells and a xenograft mouse model.

A series of semisynthetic noscapine-urea congeners (7a-7h) as potential tubulin-binding agents are being developed by integrating a urea pharmacophore at the C-9 position of the noscapine scaffold. Their binding affinity to tubulin was predicted through molecular docking, molecular dynamics (MD) simulations, and the MM-PBSA approach. These molecules were subsequently chemically synthesized and assessed using breast cancer cell lines (MCF-7 and MDA-MB-231) and normal human embryonic kidney cells (HEK).

Splenic artery aneurysm and infarction during pregnancy from infective endocarditis.

Rheumatic heart disease (RHD) remains the leading cardiac problem affecting pregnant women, especially in low- to middle-income countries. In nearly one-third of the cases, it is detected during pregnancy when they present with complications. Infective endocarditis (IE) in pregnancy is rare, with an incidence of 1 in 100 000 pregnancies, and carries high maternal and fetal morbidity and mortality.